https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-04-04 / J Cancer Metastasis Treat 2023;9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-04-04 / J Cancer Metastasis Treat 2023;92023-04-04 00:00:002023-04-04 00:00:00Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-03-15 / Front Cell Infect Microbiol 2023;13:1142172
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-03-15 / Front Cell Infect Microbiol 2023;13:11421722023-03-15 00:00:002023-03-15 00:00:00Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-200
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-2002023-02-17 00:00:002023-02-17 00:00:00Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-01 / J Med Virol 2023 Feb;95(2):e28554
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-01 / J Med Virol 2023 Feb;95(2):e285542023-02-01 00:00:002023-02-01 00:00:00Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-31 / Expert Opin Drug Discov 2023 Jan;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-31 / Expert Opin Drug Discov 2023 Jan;2023-01-31 00:00:002023-01-31 00:00:00Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-12-01 / Transl Pediatr 2022 Dec;11(12):2040-2056
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-12-01 / Transl Pediatr 2022 Dec;11(12):2040-20562022-12-01 00:00:002024-01-30 11:22:05Immunotherapy for the treatment of pediatric brain tumors: a narrative review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-11-26 / J Clin Med 2022 Nov;11(23)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-11-26 / J Clin Med 2022 Nov;11(23)2022-11-26 00:00:002023-01-31 13:00:05Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-09-18 / Curr Oncol 2022 Sep;29(9):6700-6713
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-09-18 / Curr Oncol 2022 Sep;29(9):6700-67132022-09-18 00:00:002022-09-27 14:47:20Immunogenic Cell Death Role in Urothelial Cancer Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-09-12 / Front Mol Biosci 2022;9:754100
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-09-12 / Front Mol Biosci 2022;9:7541002022-09-12 00:00:002022-09-12 00:00:003-Dimensional coculture of breast cancer cell lines with adipose tissue-Derived stem cells reveals the efficiency of oncolytic Newcastle disease virus infection labeling technology
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-09-06 / Molecules 2022 Sep;27(18)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-09-06 / Molecules 2022 Sep;27(18)2022-09-06 00:00:002022-09-06 00:00:00Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy
